晚期糖基化终末产物（AGEs）网络研讨会会议报告
Advanced Glycation End Products (AGEs) Webinar Meeting Report.
作者信息
Ho Cindy N, Ayers Alessandra T, Beisswenger Paul, Chalew Stuart, Schmidt Ann Marie, Pandey Ambarish, Kapahi Pankaj, Fleming Alexander, Klonoff David C
机构信息
Diabetes Technology Society, Burlingame, CA, USA.
Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
出版信息
J Diabetes Sci Technol. 2025 Mar;19(2):576-581. doi: 10.1177/19322968241296541. Epub 2024 Nov 7.
Abstract
The advanced glycation end products (AGEs) Webinar was co-hosted by Diabetes Technology Society and Kitalys Institute on August 8, 2024, with the goal of reviewing progress made in the measurement and use of AGEs in clinical practice. Meeting topics included (1) AGEs as predictors of diabetic nephropathy (DKD), (2) hemoglobin glycation index (HGI) and the glycation gap (GG), (3) formation and structure of AGEs, (4) AGEs as a risk factor of cardiovascular disease (CVD), and (5) approaches to limit or prevent AGE formation.
摘要
2024年8月8日，晚期糖基化终末产物（AGEs）网络研讨会由糖尿病技术协会和基塔利斯研究所联合主办，目的是回顾AGEs在临床实践中的测量和应用方面取得的进展。会议主题包括：（1）AGEs作为糖尿病肾病（DKD）的预测指标；（2）血红蛋白糖化指数（HGI）和糖化差距（GG）；（3）AGEs的形成和结构；（4）AGEs作为心血管疾病（CVD）的危险因素；（5）限制或预防AGEs形成的方法。
相似文献
1
Advanced Glycation End Products (AGEs) Webinar Meeting Report.
J Diabetes Sci Technol. 2025 Mar;19(2):576-581. doi: 10.1177/19322968241296541. Epub 2024 Nov 7.
2
The role of advanced glycation end products between thyroid function and diabetic nephropathy and metabolic disorders.
Sci Rep. 2025 Feb 28;15(1):7202. doi: 10.1038/s41598-025-88806-7.
3
Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2457-2461. doi: 10.1016/j.dsx.2019.06.019. Epub 2019 Jun 28.
4
Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
Circ J. 2019 Aug 23;83(9):1822-1828. doi: 10.1253/circj.CJ-19-0618. Epub 2019 Jul 30.
5
The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.
Cardiovasc Diabetol. 2008 Oct 7;7:29. doi: 10.1186/1475-2840-7-29.
6
Role of advanced glycation end products and insulin resistance in diabetic nephropathy.
Arch Physiol Biochem. 2023 Feb;129(1):95-107. doi: 10.1080/13813455.2020.1797106. Epub 2020 Jul 30.
7
Non-enzymatic glycation and diabetic kidney disease.
Vitam Horm. 2024;125:251-285. doi: 10.1016/bs.vh.2024.01.002. Epub 2024 Feb 6.
8
Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes.
Cardiovasc Diabetol. 2024 Jul 4;23(1):235. doi: 10.1186/s12933-024-02316-w.
9
A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy.
Curr Protein Pept Sci. 2023;24(1):2-6. doi: 10.2174/1389203724666221108120715.
10
Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.
J Diabetes. 2017 Feb;9(2):141-148. doi: 10.1111/1753-0407.12475. Epub 2016 Sep 25.
引用本文的文献
1
Glycosylation in kidney diseases.
Precis Clin Med. 2025 Jul 11;8(3):pbaf017. doi: 10.1093/pcmedi/pbaf017. eCollection 2025 Sep.
2
Association Between the Hemoglobin Glycation Index (HGI) and Risk of Diabetic Nephropathy: A Retrospective Cohort Study.
Diabetes Metab Syndr Obes. 2025 Jun 5;18:1859-1872. doi: 10.2147/DMSO.S523442. eCollection 2025.
3
Correlation analysis between hemoglobin and type 2 diabetic nephropathy: a two-center retrospective study.
Acta Diabetol. 2025 Jun 5. doi: 10.1007/s00592-025-02529-9.
4
Estimated glucose disposal rate mediates the association between Life's Crucial 9 and congestive heart failure: a population-based study.
Front Endocrinol (Lausanne). 2025 Apr 3;16:1540794. doi: 10.3389/fendo.2025.1540794. eCollection 2025.
本文引用的文献
1
Anti-ageing interventions for the treatment of cardiovascular disease.
Cardiovasc Res. 2024 Aug 22. doi: 10.1093/cvr/cvae177.
2
Non-Hispanic Black Individuals Have Higher Glucose-Adjusted HbA1c Levels and Risk for Severe Hypoglycemia: Evidence From the Diabetes Control and Complications Trial.
Diabetes Care. 2024 Aug 1;47(8):e59-e60. doi: 10.2337/dc24-0299.
3
Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia.
J Diabetes Sci Technol. 2024 Mar 25:19322968241240436. doi: 10.1177/19322968241240436.
4
Accumulation of advanced glycation end products in skin and increased vascular ageing in the general population: the Malmö Offspring Study.
J Hypertens. 2024 Mar 1;42(3):530-537. doi: 10.1097/HJH.0000000000003627. Epub 2023 Dec 4.
5
Determination of Glucose-Independent Racial Disparity in HbA1c for Youth With Type 1 Diabetes in the Era of Continuous Glucose Monitoring.
J Diabetes Sci Technol. 2025 Jan;19(1):72-79. doi: 10.1177/19322968231199113. Epub 2023 Sep 12.
6
Novel biomarkers for prognosticating diabetic kidney disease progression.
Int Urol Nephrol. 2023 Apr;55(4):913-928. doi: 10.1007/s11255-022-03354-7. Epub 2022 Oct 22.
7
The Human Glyoxalase Gene Family in Health and Disease.
Chem Res Toxicol. 2022 Oct 17;35(10):1766-1776. doi: 10.1021/acs.chemrestox.2c00182. Epub 2022 Sep 1.
8
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
Curr Drug Targets. 2022;23(12):1191-1209. doi: 10.2174/1389450123666220610171005.
9
Variation in the hemoglobin glycation index.
J Diabetes Complications. 2022 Jul;36(7):108223. doi: 10.1016/j.jdiacomp.2022.108223. Epub 2022 Jun 2.
10
The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases.
Int J Mol Sci. 2022 Mar 22;23(7):3439. doi: 10.3390/ijms23073439.
Zotero 插件